Detail of the session

Back to list of sessions

Type :
FOCUS SESSION 8

Date :
Saturday 27^th April 2019

Schedule :
08h30 - 10h00

Session Title :

FS08 - Focus Session 8: Individualized Therapy in Major Inflammatory Skin Diseases

O060
08h30 - 08h45

Treat to target
Alexander NAST - Germany

O061
08h45 - 09h00

Transitioning between biologics
Ronald VENDER - Canada

O062
09h00 - 09h15

Combination therapy
Pablo COTO - Spain

O063
09h15 - 09h30

Therapeutic drug monitoring in biologics
Ann GILS - Belgium

P014
09h30 - 09h35

IDENTIFICATION OF CLINICAL AND BIOMARKER PARAMETERS ASSOCIATED WITH LONG-TERM MAINTENANCE OF PASI 90 RESPONSE FOLLOWING GUSELKUMAB TREATMENT WITHDRAWAL IN PSORIASIS
Xuejun LIU - United States

P015
09h35 - 09h40

DEFINING A MINIMAL EFFECTIVE SERUM TROUGH CONCENTRATION OF SECUKINUMAB IN PSORIASIS: A STEP TOWARDS PERSONALIZED THERAPY
Jo LAMBERT - Belgium

P024
09h40 - 09h45

FOLLOW-UP OF PATIENTS WITH PSORIASIS IN COMMUNITY PHARMACY
Joana FERREIRA - Portugal